These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4020242)

  • 21. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
    Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease.
    Richardson DR; Chua AC; Baker E
    J Lab Clin Med; 1999 Feb; 133(2):144-51. PubMed ID: 9989766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization.
    Laub R; Schneider YJ; Octave JN; Trouet A; Crichton RR
    Biochem Pharmacol; 1985 Apr; 34(8):1175-83. PubMed ID: 3994740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG; Randell EW; Olivieri NF; Templeton DM
    Biochim Biophys Acta; 1995 Apr; 1243(3):373-80. PubMed ID: 7727512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of uptake of transferrin-bound iron by human hepatoma cells by nontransferrin-bound iron.
    Trinder D; Morgan E
    Hepatology; 1997 Sep; 26(3):691-8. PubMed ID: 9303500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
    Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of iron by isolated rat hepatocytes from a hydrophilic impermeant ferric chelate, Fe(III)-DTPA.
    Scheiber B; Goldenberg H
    Arch Biochem Biophys; 1996 Feb; 326(2):185-92. PubMed ID: 8611022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemosiderosis in rodents and the effect of acetohydroxamic acid on urinary iron excretion.
    Corden BJ
    Exp Hematol; 1986 Nov; 14(10):971-4. PubMed ID: 3770104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
    Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P
    Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine.
    Suzer T; Coskun E; Demir S; Tahta K
    Res Exp Med (Berl); 2000 Feb; 199(4):223-9. PubMed ID: 10743680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of chelating agents on iron mobilization in Chang cell cultures.
    White GP; Jacobs A; Grady RW; Cerami A
    Blood; 1976 Dec; 48(6):923-9. PubMed ID: 1000084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrastructural pathology of iron-loaded rat myocardial cells in culture.
    Iancu TC; Shiloh H; Link G; Bauminger ER; Pinson A; Hershko C
    Br J Exp Pathol; 1987 Feb; 68(1):53-65. PubMed ID: 3814501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis.
    Craven CM; Alexander J; Eldridge M; Kushner JP; Bernstein S; Kaplan J
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3457-61. PubMed ID: 3472216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferrin and iron release from rat hepatocytes in culture.
    Baker E; Page M; Morgan EH
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G93-7. PubMed ID: 3966565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ; Johnson DK; Finch CA
    Br J Haematol; 1982 Oct; 52(2):211-24. PubMed ID: 7126464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte transferrin-iron uptake in hereditary hemochromatosis.
    Sizemore DJ; Bassett ML
    Am J Hematol; 1984 May; 16(4):347-54. PubMed ID: 6720680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway.
    Kwok JC; Richardson DR
    Mol Pharmacol; 2003 Apr; 63(4):849-61. PubMed ID: 12644586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron uptake by Chang cells from transferrin, nitriloacetate and citrate complexes: the effects of iron-loading and chelation with desferrioxamine.
    White GP; Jacobs A
    Biochim Biophys Acta; 1978 Oct; 543(2):217-25. PubMed ID: 728460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of iron chelation in the hypertransfused rat: definition of two alternative pathways of iron mobilization.
    Hershko C; Grady RW; Cerami A
    J Lab Clin Med; 1978 Aug; 92(2):144-51. PubMed ID: 681807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.